A Phase I Study of Two Different Doses of the Subcutaneous Administration of an Immunotherapeutic Vaccine, DPX-0907 in Advanced Stage Patients With Ovarian, Breast or Prostate Cancer.
Phase of Trial: Phase I
Latest Information Update: 18 Dec 2015
At a glance
- Drugs DPX 0907 (Primary)
- Indications Breast cancer; Ovarian cancer; Prostate cancer
- Focus Adverse reactions
- 06 Aug 2012 Results were published in the Journal of Translational Medicine, according to an Immunovaccine media release. Results were also reported in the media release.
- 04 Jun 2012 Results have been presented at ASCO-2012 according to an Immunovaccine media release. Results were also summarised in the media release.
- 29 May 2012 Further results will be reported at the American Society of Clinical Oncology (ASCO) 2012 Annual Meeting, according to an Immunovaccine media release.